Dr Calvin Stiller
Guest ContributorJanuary 24, 2006
Dr Calvin Stiller and Dr Ronald Cresswell have appointed to the board of directors of Vasogen Inc, a Toronto-based developer of technologies targetting inflammation related to cardiovascular and neurological diseases. Stiller has a strong medical and venture capital background, while Cresswell is a veteran executive of several multinational pharmaceuti
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 1 free article remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.